Joel Greenblatt Gain Therapeutics, Inc. Transaction History
Gotham Asset Management, LLC
- $9.41 Billion
- Q3 2024
A detailed history of Joel Greenblatt (Gotham Asset Management, LLC) transactions in Gain Therapeutics, Inc. stock. As of the latest transaction made, Gotham Asset Management, LLC holds 334,592 shares of GANX stock, worth $588,881. This represents 0.01% of its overall portfolio holdings.
Number of Shares
334,592Holding current value
$588,881% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding GANX
# of Institutions
23Shares Held
2.39MCall Options Held
10KPut Options Held
0-
David Einhorn Greenlight Capital Inc | New York, Ny588KShares$1.04 Million0.1% of portfolio
-
Dme Capital Management, LP New York, NY566KShares$996,3880.04% of portfolio
-
Geode Capital Management, LLC Boston, MA272KShares$478,6700.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA145KShares$255,5810.0% of portfolio
-
Telemetry Investments, L.L.C. New York, NY123KShares$216,4800.61% of portfolio
About Gain Therapeutics, Inc.
- Ticker GANX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,883,400
- Market Cap $20.9M
- Description
- Gain Therapeutics, Inc., a biotechnology company, engages in developing various therapies to treat diseases caused by protein misfolding. It focuses on rare genetic diseases and neurological disorders. The company uses its Site-Directed Enzyme Enhancement Therapy platform to discover allosteric sites on misfolded proteins and identify proprietar...